Podcasts about preventing overdiagnosis

Ray Moynihan is an accomplished health journalist and author who has won several awards for his work. He is also an academic at Bond University and a documentary filmmaker. Moynihan's research and writing focus on the healthcare industry, with an emphasis on how diseases are created, branded, and marketed to unsuspecting people. He is known for his use of sharp humor, which can be seen in his mock documentary about a fictional illness called 'Motivational Deficiency Disorder.' He is also a founding member of the international conference Preventing Overdiagnosis and hosts the podcast The Recommended Dose. Today, we will be discussing something that the speaker refers to as "an assault on being human" - the labeling of everyday life struggles as disorders and how patient advocacy groups, doctors, medical journalists, and respected academics are often manipulated by a powerful, corporatized healthcare system. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. Mad in America podcasts and reports are made possible, in part, by a grant from the Thomas Jobe Fund. To find the Mad in America podcast on your preferred podcast player, click here

In this month's Talk Evidence, Helen and Juan are reporting from Preventing Overdiagnosis - the conference that raises issues of diagnostic accuracy, and asks if starting the process of medicalisation is always the right thing to do for patients.   In this episode, they talk about home testing, sustainability and screening. They're also joined by two guests to talk about the overdiagnosis of obesity - when that label is stigmatising and there seem to be few successful treatments that medicine can offer, and the need to educate students in the concepts of overdiagnosis and too much medicine, to create a culture change in medicine.   Links; The Preventing Overdiagnosis conference The BMJ EBM papers on choosing wisely.  

In this month's Talk Evidence, Helen and Juan are reporting from Preventing Overdiagnosis - the conference that raises issues of diagnostic accuracy, and asks if starting the process of medicalisation is always the right thing to do for patients.   In this episode, they talk about home testing, sustainability and screening. They're also joined by two guests to talk about the overdiagnosis of obesity - when that label is stigmatising and there seem to be few successful treatments that medicine can offer, and the need to educate students in the concepts of overdiagnosis and too much medicine, to create a culture change in medicine.   Links; The Preventing Overdiagnosis conference The BMJ EBM papers on choosing wisely.

Fiona Godlee, Editor in Chief of The BMJ, gives a talk for the EBHC podcast series Fiona Godlee is the Editor in Chief of The BMJ. She qualified as a doctor in 1985, trained as a general physician in Cambridge and London, and is a Fellow of the Royal College of Physicians. She has written and lectured on a broad range of issues, including health and the environment, the ethics of academic publishing, evidence based medicine, access to clinical trial data, research integrity, open access publishing, patient partnership, conflict of interest, and overdiagnosis and overtreatment. After joining The BMJ as an assistant editor in 1990, she moved in 2000 to help establish the open access publisher BioMedCentral as its founding Editorial Director for Medicine. In 2003 she returned to BMJ to lead its Knowledge division and was appointed Editor in Chief of The BMJ in March 2005. Fiona is honorary professor at the Netherlands School for Primary Care Research (CaRe), honorary fellow of the Royal College of General Practitioners, a senior visiting fellow at the Institute of Public Health at the University of Cambridge, honorary fellow of the Faculty of Public Health and a by-fellow of King's College Cambridge. She is on the advisory or executive boards of the Health Improvement Studies (THIS) Institute (thisinstitute.cam.ac.uk), Alltrials (alltrials.net), the Peer Review Congress (peerreviewcongress.org), the International Forum for Quality and Safety and Healthcare (internationalforum.bmj.com), Evidence Live (evidencelive.org), Preventing Overdiagnosis (preventingoverdiagnosis.net), the UK Health Alliance on Climate Change (ukhealthalliance.org) and the Climate and Health Council. She was a Harkness Fellow (1994-5), President of the World Association of Medical Editors (WAME) (1998-2000), Chair of the Committee on Publication Ethics (COPE) (2003-5), and PPA Editor of the Year (2014). Fiona is co-editor of Peer Review in Health Sciences. She lives in Cambridge with her husband and two children.

Fiona Godlee, Editor in Chief of The BMJ, gives a talk for the EBHC podcast series Fiona Godlee is the Editor in Chief of The BMJ. She qualified as a doctor in 1985, trained as a general physician in Cambridge and London, and is a Fellow of the Royal College of Physicians. She has written and lectured on a broad range of issues, including health and the environment, the ethics of academic publishing, evidence based medicine, access to clinical trial data, research integrity, open access publishing, patient partnership, conflict of interest, and overdiagnosis and overtreatment. After joining The BMJ as an assistant editor in 1990, she moved in 2000 to help establish the open access publisher BioMedCentral as its founding Editorial Director for Medicine. In 2003 she returned to BMJ to lead its Knowledge division and was appointed Editor in Chief of The BMJ in March 2005. Fiona is honorary professor at the Netherlands School for Primary Care Research (CaRe), honorary fellow of the Royal College of General Practitioners, a senior visiting fellow at the Institute of Public Health at the University of Cambridge, honorary fellow of the Faculty of Public Health and a by-fellow of King’s College Cambridge. She is on the advisory or executive boards of the Health Improvement Studies (THIS) Institute (thisinstitute.cam.ac.uk), Alltrials (alltrials.net), the Peer Review Congress (peerreviewcongress.org), the International Forum for Quality and Safety and Healthcare (internationalforum.bmj.com), Evidence Live (evidencelive.org), Preventing Overdiagnosis (preventingoverdiagnosis.net), the UK Health Alliance on Climate Change (ukhealthalliance.org) and the Climate and Health Council. She was a Harkness Fellow (1994-5), President of the World Association of Medical Editors (WAME) (1998-2000), Chair of the Committee on Publication Ethics (COPE) (2003-5), and PPA Editor of the Year (2014). Fiona is co-editor of Peer Review in Health Sciences. She lives in Cambridge with her husband and two children.

Do I really need this test, treatment or procedure? What are the downsides? What happens if I do nothing? And are there simpler, safer alternatives?   Dr. Ray Moynihan (@raymoynihan) joins BJSM’s Daniel Friedman (@ddfriedman) to discuss the growing problem of overdiagnosis and overtreatment, and what is being done to wind back the harms of too much medicine.       Ray is an Australian academic, author and award-winning health journalist who completed his PhD on overdiagnosis in 2015 at the Centre for Research in Evidence-Based Practice at Bond University in Australia, where he is also a senior research fellow. Having reported across print, radio, television and social media, Dr Moynihan has worked at the ABC TV’s investigative program, Four Corners and the 7:30 Report, and The Australian Financial Review. He has also developed an impressive body of academic work published in the Lancet, the New England Journal of Medicine, PLOS ONE and the BMJ.   Dr. Moynihan has won several awards for his investigative journalism, and his book ‘Selling Sickness’ (2005) was described in the New York Times as a “compelling case” and has been translated into a dozen languages. His fourth book, ‘Sex, Lies & Pharmaceuticals’ was released globally in 2010 and generated widespread interest internationally.   Dr Moynihan hosts the very popular podcast, ‘The Recommended Dose’, that is produced by Cochrane Australia and co-published by the BMJ. https://soundcloud.com/therecodo   In this 25 minute conversation, Dr Moynihan explains the drivers of too much medicine and addresses:        embracing healthy scepticism in healthcare        the threat of too much medicine to our health        the problem with diagnostic labels        his ground-breaking discovery of a dangerous new disease        what clinicians should do to practice ‘just the right amount’ of medicine (Goldilocks Principle)

The concept of overdiagnosis is pretty hard to get - especially if you've been educated in a paradigm where medicine has the answers, and it's only every a positive intervention in someone's life - the journey to understanding the flip side - that sometimes medicine can harm often takes what Stacey Carter director of Research for Social Change at Wollongong university described in an preventing overdiagnosis podcast last year as a “moral shock” - https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation This year, we asked some of the leaders in the field to describe what it was that opened their eyes to overdiagnosis and overtreatment - and recorded the session for you. You'll hear from Fiona Godlee, editor in Chief of The BMJ, Steve Woloshin and Lisa Schwartz, directors of the Center for Medicine and Media at The Dartmouth Institute, John Brodersen - professor of general practice at the University of Copenhagen, and Barry Kramer - director of the Division of Cancer Prevention at the U.S. National cancer institute. The

This week saw the latest Preventing Overdiagnosis conference - this time in Copenhagen. The conference is a is a forum where researchers and practitioners can present examples of overdiagnosis - and we heard about the various ways which disease definitions are being subtly widened, and diagnostic thresholds lowered. In this podcast we talk to Allen Frances, psychiatrist and former chair of the Diagnostic and Statistical Manual of Mental Disorders. We also hear from friends of the podcast, Steve Woloshin and Lisa Schwartz about the way in which some disease awareness campaigns fuel inappropriate diagnosis. https://www.preventingoverdiagnosis.net/ https://www.bmj.com/too-much-medicine

In our last podcast from Preventing Overdiagnosis 2017, we convened an impromptu roundtable of clinicians who are attending the conference to see how some of the big themes that were discussed at the conference are going to impact their everyday practice. Joining us were; Jessica Otte - Family physician from Canada David Warriner - Cardiologist from the UK. Jack O'Sullivan - Junior doctor from Australia Imran Sajid - GP from the UK To read more, have a look at our Too much medicine campaign - bmj.com/too-much-medicine.

The Preventing overdiagnosis conference covers how physicians, researchers and patients can implement solutions to the problems of over diagnosis and overuse in healthcare. If you're a doctor on twitter, you've probably come across our guest - Vinay Prasad, assistant prof. of medicine at Oregon Health and Science University, and author of the book Ending Medical Reversal.

This week we're at the over diagnosis conference in Quebec Canada, Preventing overdiangosis is a forum to discuss the harms associated with using uncertain methods to look for disease in apparently healthy people - and is part of the BMJ's too much medicine campaign. One of the ways in which the public's attitudes and wishes around health is measured are citizen or community juries - set up in a similar way to a criminal jury - with an information gathering, and a deliberation phase - recently one of these citizen juries discussed, whether abortion should be allowed in Ireland (they decided “yes”). We're joined by Rae Thomas, from Bond University and Chris Degeling, from the University of Sydney, who have both been using citizen juries to look at over diagnosis.

This week we're at the Preventing Overdiagnosis conference in Quebec Canada, The conference is a forum to discuss the harms associated with using uncertain methods to look for disease in apparently healthy people - and is part of the BMJ's too much medicine campaign. The literature on overdiagnosis has mostly been published since 2013 - partly because of The BMJ, but in large part because of the work of Rita Redberg, professor of clinical medicine, and a working cardiologist, at UCSF, and editor of JAMA internal medicine who joins us to discuss why less is more.

In this interview from Preventing Overdiagnosis 2017 (preventingoverdiagnosis.net) Stacy Carter, associate professor at Sydney Health Ethics - and the author of a recently written BMJ essay the ethical aspects of overdiagnosis, joins us to talk about how the cultural context of medicine seeps into our decision making processes and affects how people conceptualise the risks of too much medicine. Read Stacy's full essay: http://www.bmj.com/content/358/bmj.j3872

Overdiagnosis is the diagnosis of "disease" that will never cause symptoms or death during a patient's lifetime. Newer, more accurate technologies, and the desire to detect disease even earlier means Overdiagnosis is on the rise. Understanding the impact of Overdiagnosis, how to detect it and what to do about it might stem its inexplicable rise and prevent the epidemic of unnecessary testing. Professor Carl Heneghan is a board member of the Preventing Overdiagnosis conference and has an active interest in diagnostic reasoning and how this can, or in some cases cannot, make a real difference to patient outcomes. He is also Professor of Evidence-Based Medicine at the Department of Primary Care Health Sciences at the University of Oxford, Director of the Centre for Evidence-Based Medicine, a fellow of Kellogg College and an NHS Honorary Clinical Consultant and GP.

Overdiagnosis is the diagnosis of "disease" that will never cause symptoms or death during a patient's lifetime. Newer, more accurate technologies, and the desire to detect disease even earlier means Overdiagnosis is on the rise. Understanding the impact of Overdiagnosis, how to detect it and what to do about it might stem its inexplicable rise and prevent the epidemic of unnecessary testing. Professor Carl Heneghan is a board member of the Preventing Overdiagnosis conference and has an active interest in diagnostic reasoning and how this can, or in some cases cannot, make a real difference to patient outcomes. He is also Professor of Evidence-Based Medicine at the Department of Primary Care Health Sciences at the University of Oxford, Director of the Centre for Evidence-Based Medicine, a fellow of Kellogg College and an NHS Honorary Clinical Consultant and GP.

Catherine Calderwood has been chief medical officer for Scotland since March 2015 - her first CMO report, which she titled “Realistic Medicine” has created a stir beyond the borders of Scotland. The BMJ, sat down with Catherine at a the Preventing Overdiagnosis conference to find out what she intended with that report. Read more: http://www.bmj.com/content/355/bmj.i5455

The Preventing Overdiagnosis conference is part of The BMJ's campaign against Too Much Medicine. Helen Macdonald clinical editor for The BMJ was at the conference, and talked to some of the key speakers there about what they believe the key issues are, and what's being done to roll back the harms of too much medicine. http://www.bmj.com/too-much-medicine http://www.preventingoverdiagnosis.net/

Dr. Teppo Järvinen appears on the international "Too Much Medicine" stage with his concerns about the way osteoporosis - bone thinning - is diagnosed and treated. Järvinen is an orthopedic surgeon and sports medicine specialist in Helsinki, Finland. I interviewed him at the Preventing Overdiagnosis 2015 conference at the National Institutes of Health.

Dr. Otis Brawley is the chief medical officer of the American Cancer Society. He has provided a strong, clear voice on cancer screening, treatment and research issues. In this podcast, he says that the belief continues that a cancer will kill because it looks like other cancers that spread and killed in the 1850s. He calls this “pathologic profiling” of cancer – and of the people who are diagnosed – based on 160-year old laboratory standards. I interviewed him at the Preventing Overdiagnosis 2015 conference at the National Institutes of Health.

Surgeon and breast cancer specialist Dr. Laura Esserman of the University of California San Francisco is one of the innovative thought leaders in breast cancer research. We talked with her at the Preventing Overdiagnosis 2015 conference at the National Institutes of Health, discussing, among other things, the treatment dilemma facing women diagnosed with DCIS or ductal carcinoma in situ.

Are doctors over-diagnosing diabetes? Such concerns have been raised - by Dr. Victor Montori of the Mayo Clinic and Dr. John S. Yudkin of University College in London. A special concern is the new category of "pre-diabetes." Yudkin is featured in this podcast episode. He talks about the "idolatry of the surrogate" - bowing to a golden calf - a false idol - of numbers from a blood sugar test "as if worthy of godlike worship whereas they should not be.” I interviewed him at the Preventing Overdiagnosis 2015 conference at the National Institutes of Health.

Although overuse in medicine is gaining increased attention, many questions remain unanswered. At the Preventing Overdiagnosis conference in Washington, Dan Morgan, associate professor at the University of Maryland School of Medicine, and Sanket Dhruva, research fellow at Yale University, propose an agenda for coordinated research to improve our understanding of the problem. Read the full agenda at: http://www.bmj.com/content/351/bmj.h4534

Screening tests were central to many of the discussions taking place at the Preventing Overdiagnosis conference (preventingoverdiagnosis.net) To sum up some of the problems with screening we're joined by Carl Heneghan, director of the Centre for Evidence Based Medicine at the University of Oxford, and John Broderson, associate professor in the Research Unit and Section of General Practice at the University of Copenhagen. For more on over diagnosis, visit www.bmj.com/too-much-medicine